DAFNA Capital Management LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 65 filers reported holding IMMUNE DESIGN CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2018$1,133,000
-24.2%
328,5000.0%0.46%
-33.6%
Q2 2018$1,495,000
+37.9%
328,5000.0%0.70%
+32.8%
Q1 2018$1,084,000
-15.4%
328,5000.0%0.53%
-23.6%
Q4 2017$1,281,000
+322.8%
328,500
+721.2%
0.69%
+227.0%
Q3 2016$303,00040,0000.21%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2018
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders